460 related articles for article (PubMed ID: 12149192)
21. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
Hiller O; Lichte A; Oberpichler A; Kocourek A; Tschesche H
J Biol Chem; 2000 Oct; 275(42):33008-13. PubMed ID: 10930399
[TBL] [Abstract][Full Text] [Related]
23. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
[TBL] [Abstract][Full Text] [Related]
25. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B.
Moore UM; Kaplow JM; Pleass RD; Castro SW; Naik K; Lynch CN; Daly S; Roach AG; Jaye M; Williams RJ
J Leukoc Biol; 1997 Dec; 62(6):911-5. PubMed ID: 9400834
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
Li X; Tai HH
Mol Carcinog; 2014 Aug; 53(8):659-66. PubMed ID: 23475608
[TBL] [Abstract][Full Text] [Related]
27. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody.
Reid C; Rushe M; Jarpe M; van Vlijmen H; Dolinski B; Qian F; Cachero TG; Cuervo H; Yanachkova M; Nwankwo C; Wang X; Etienne N; Garber E; Bailly V; de Fougerolles A; Boriack-Sjodin PA
Protein Eng Des Sel; 2006 Jul; 19(7):317-24. PubMed ID: 16682434
[TBL] [Abstract][Full Text] [Related]
28. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
[TBL] [Abstract][Full Text] [Related]
29. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).
Agnihotri R; Crawford HC; Haro H; Matrisian LM; Havrda MC; Liaw L
J Biol Chem; 2001 Jul; 276(30):28261-7. PubMed ID: 11375993
[TBL] [Abstract][Full Text] [Related]
31. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
[TBL] [Abstract][Full Text] [Related]
32. Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16.
Starr AE; Dufour A; Maier J; Overall CM
J Biol Chem; 2012 Feb; 287(8):5848-60. PubMed ID: 22147696
[TBL] [Abstract][Full Text] [Related]
33. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
34. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis.
Gálvez BG; Genís L; Matías-Román S; Oblander SA; Tryggvason K; Apte SS; Arroyo AG
J Biol Chem; 2005 Jan; 280(2):1292-8. PubMed ID: 15516694
[TBL] [Abstract][Full Text] [Related]
35. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ
Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
[TBL] [Abstract][Full Text] [Related]
36. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
38. Degradation of interleukin 1beta by matrix metalloproteinases.
Ito A; Mukaiyama A; Itoh Y; Nagase H; Thogersen IB; Enghild JJ; Sasaguri Y; Mori Y
J Biol Chem; 1996 Jun; 271(25):14657-60. PubMed ID: 8663297
[TBL] [Abstract][Full Text] [Related]
39. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase.
Van den Steen PE; Husson SJ; Proost P; Van Damme J; Opdenakker G
Biochem Biophys Res Commun; 2003 Oct; 310(3):889-96. PubMed ID: 14550288
[TBL] [Abstract][Full Text] [Related]
40. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M; Chvyrkova I; Bernardo MM; Hernandez-Barrantes S; Fridman R
Biochem Biophys Res Commun; 2003 Aug; 308(2):386-95. PubMed ID: 12901881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
